Opinion|Videos|April 4, 2025
Key Takeaways on GEP Testing in Melanoma and SCC
Author(s)David Cotter, MD, PhD
An expert discusses when gene expression profile (GEP) testing is recommended for melanoma and squamous cell carcinoma (SCC) patients, including cases where it may not be necessary, and provides final thoughts on the utility of GEP testing in risk stratification and making treatment decisions.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- When do you recommend GEP testing for melanoma and SCC patients? Are there cases where GEP testing is not necessary?
- Give your final thoughts on GEP testing for melanoma and SCC and its utility in risk stratification and making treatment decisions.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Transformative Advances This Year and Beyond
2
FDA Proposes Expansion of US Sunscreen Ingredient Standards with Bemotrizinol
3
Phase 3b Study Confirms Ligelizumab’s Consistent CSU Control
4
"PDE4 Inhibitor-Responsive Dermatoses": A Modern Framework for Managing Inflammatory Skin Conditions
5
